מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK), SODIUM CITRATE (UNII: 1Q73Q2JULR) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL), CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)
Haemonetics Manufacturing Inc
INTRAVENOUS
PRESCRIPTION DRUG
For use with automated pheresis equipment only. Use according to equipment manufacturer’s instructions. This unit should be used for pheresis only. Not for direct intravenous infusion.
750 mL volume bag. Each 100 ml contains: 0.73 g citric acid (anhydrous), USP 2.20 g sodium citrate (dihydrate), USP 2.45 g dextrose (monohydrate), USP
New Drug Application
ACD-A- ANTICOAGULANT CITRATE DEXTROSE SOLUTION A SOLUTION HAEMONETICS MANUFACTURING INC ---------- ANTICOAGULANT CITRATE DEXTROSE SOLUTION, USP (ACD), SOLUTION A DESCRIPTION Re-Order Product Code: 796-08 750 mL volume. Single use container. Sterile, nonpyrogenic fluid path. Sterilized by steam. Store at room temperature. INDICATIONS AND USAGE For use with automated pheresis equipment only. Use according to equipment manufacturer’s instructions. This unit should be used for pheresis only. CONTRAINDICATIONS Not for direct intravenous infusion. WARNINGS Avoid excessive heat. Protect from freezing. PRECAUTIONS Do not use unless solution is clear and no leaks detected. GENERAL Rx only. Discard unused portion. Recommended Storage: Store at room temperature (25°C / 77°F). HOW SUPPLIED 750 mL volume bag. Each 100 ml contains: 0.73 g citric acid (anhydrous), USP 2.20 g sodium citrate (dihydrate), USP 2.45 g dextrose (monohydrate), USP PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Hot Stamped Bag Envelope Label REFERENCES HAEMONETICS and THE Blood Management Company are trademarks of Haemonetics Corporation. Manufactured for: Haemonetics Corporation 400 Wood Road Braintree, MA 02184, USA By: Haemonetics Manufacturing Inc. Haemonetics Manufacturing Inc 1630 Industrial Park Street Covina, CA 91722, USA ACD-A anticoagulant citrate dextrose solution a solution PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:53157-79 6 ROUTE OF ADMINISTRATION INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DEXTRO SE MO NO HYDRATE (UNII: LX22YL0 8 3G) (ANHYDROUS DEXTROSE - UNII:5SL0 G7R0 OK) DEXTROSE MONOHYDRATE 2.45 g in 10 0 mL SO DIUM CITRATE (UNII: 1Q73Q2JULR) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) SODIUM CITRATE 2.20 g in 10 0 mL CITRIC ACID MO NO HYDRATE (UNII: 29 6 8 PHW8 QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 0 .73 g in 10 0 mL PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:53157-79 6 -0 8 12 i קרא את המסמך השלם